Abstract:Abstract Aims Hutchinson–Gilford progeria syndrome (HGPS) is a pre-mature aging disorder caused by the mutation of the LMNA gene leading to an irreversibly farnesylated lamin A protein: progerin. The major causes of death in HGPS are coronary and arterial occlusive disease. In the murine model of HGPS, vascular smooth muscle cell (VSMC) loss is the primary vascular manifestation, which is different from the arterial occlusive disease seen in older patients. Methods and results To identify the mechanisms of HGPS vascular disease in humans, we differentiated isogenic endothelial cells (ECs) and VSMCs from HGPS-induced pluripotent stem cells (iPSCs) and control-iPSCs. Both HGPS-ECs and HGPS-VSMCs manifested cellular hallmarks of aging, including dysmorphic nuclei, impaired proliferation, increased β-galactosidase staining, shortened telomeres, up-regulated secretion of inflammatory cytokines, increased DNA damage, loss of heterochromatin, and altered shelterin protein complex (SPC) expression. However, at similar days after differentiation, even with lower levels of progerin, HGPS-ECs manifested more severe signs of senescence, as indicated in part by a higher percentage of β-galactosidase positive cells, shorter telomere length, and more DNA damage signals. We observed increased γH2A.X binding to RAP1 and reduced TRF2 binding to lamin A in HGPS-ECs but not in HGPS-VSMCs. The expression of γH2A.X was greater in HGPS-ECs than in HGPS-VSMCs and is associated with greater telomere shortening, impaired SPC interactions, and loss of heterochromatin. Conclusion Although progerin expression has a deleterious effect on both ECs and VSMCs, the dysfunction is greater in HGPS-ECs compared with HGPS-VSMCs. This study suggests that an endothelial-targeted therapy may be useful for HGPS patients.

Mechanisms Controlling the Smooth Muscle Cell Death in Progeria Via Down-Regulation of Poly(Adp-Ribose) Polymerase 1

Vascular senescence in progeria: role of endothelial dysfunction

The Accumulation of Progerin Underlies the Loss of Aortic Smooth Muscle Cells in Hutchinson-Gilford Progeria Syndrome

Progerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cells

Mechanisms of Angiogenic Incompetence in Hutchinson-Gilford Progeria Via Downregulation of Endothelial NOS.

Progerin impairs vascular smooth muscle cell growth via the DNA damage response pathway

The Pathogenic Mechanisms and Therapeutic Strategies of Hutchinson-Gilford Progeria Syndrome

Progeria-based vascular model identifies networks associated with cardiovascular aging and disease

Mechanisms of Genome Instability in Hutchinson-Gilford Progeria

Inhibition of poly(ADP-Ribosyl)ation reduced vascular smooth muscle cells loss and improves aortic disease in a mouse model of human accelerated aging syndrome

Mechanotransduction of the vasculature in Hutchinson-Gilford Progeria Syndrome

Molecular insights into the premature aging disease progeria

Correlated Alterations in Genome Organization, Histone Methylation, and DNA–lamin A/C Interactions in Hutchinson-Gilford Progeria Syndrome

Impaired end joining induces cardiac atrophy in a Hutchinson-Gilford progeria mouse model

A Lamin A Protein Isoform Overexpressed in Hutchinson–Gilford Progeria Syndrome Interferes with Mitosis in Progeria and Normal Cells

Unique progerin C-terminal peptide ameliorates Hutchinson–Gilford progeria syndrome phenotype by rescuing BUBR1

Progerin modulates the IGF-1R/Akt signaling involved in aging

Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models

A Therapeutic Target for Vascular Protection in Hutchinson–Gilford Progeria Syndrome

Heterochromatin loss as a determinant of progerin‐induced DNA damage in Hutchinson–Gilford Progeria

Progerin and Telomere Dysfunction Collaborate to Trigger Cellular Senescence in Normal Human Fibroblasts